Agios Pharmaceuticals Inc. buy Royal Bank of Canada
Start price
19.09.24
/
50%
€43.00
Target price
19.09.25
€49.40
Performance (%)
-4.65%
Price
27.09.24
€41.00
Summary
This prediction is currently active. With a performance of -4.65%, the BUY prediction for Agios Pharmaceuticals Inc. by Royal_Bank_of_Canada is down slightly. This prediction currently runs until 19.09.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Agios Pharmaceuticals Inc. | -3.756% |
iShares Core DAX® | 3.523% |
iShares Nasdaq 100 | 1.026% |
iShares Nikkei 225® | -0.063% |
iShares S&P 500 | 0.557% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Agios Pharmaceuticals Inc. diskutieren
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $55.00 price target on the stock.
Ratings data for AGIO provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€40.40
02.08.24
02.08.24
€50.39
02.08.25
02.08.25
1.49%
27.09.24
27.09.24
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€42.20
04.06.24
04.06.24
€48.75
04.06.25
04.06.25
-2.84%
27.09.24
27.09.24
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€24.80
16.02.24
16.02.24
€38.99
16.02.25
16.02.25
65.32%
27.09.24
27.09.24